hotspot -WSS

hotspot

author：fashion 2025-09-27 22:05:45 - browse：93

BRENDAN SMIALOWSKI/AFP via Getty Images

A New York jury on Wednesday convicted the former CEO of Stimwave, a company that sold devices with dummy pieces of plastic, on two counts of health care fraud. The maximum jail sentence for each count is 20 years.

Laura Perryman led Stimwave, which sold nerve stimulation devices to combat pain, from 2010 to 2019. Under her leadership, Stimwave distorted the design of the device to better fit insurance codes, resulting in unnecessary plastic components that allowed the company to sell its products for thousands of dollars more than it otherwise could. From 2017 to 2020, the company sold nearly 8,000 devices with the non-functioning component.

STAT published new details about the Stimwave story last May, after former employees described how Perryman broke into Stimwave’s Florida headquarters to steal back devices after her termination in 2019. The fraud laid bare the limits of the Food and Drug Administration’s device surveillance system, doctors’ ability to scrutinize device effectiveness, and how impossible it is for patients to get answers about the implants they receive.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Medicare drug price negotiation continues, as pharma counteroffers

WSS

App could help diagnose ear infections more accurately — and at home

The untold story of TV’s first prescription drug ad

Harvard's David Sinclair gets blowback over aging

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Leading voice in opioid treatment defends methadone clinic system

hotspot

hotspot

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Intermittent fasting comes with a heart risk? Not so fast

After affirmative action ruling, medical educators look to 'holistic review'

Gene editing the human germline: What are the risks?

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Creating egg and sperm cells from stem cells raises ethical issues

Supreme Court strikes down use of affirmative action

Harvard's David Sinclair gets blowback over aging

Novavax promises a turnaround & Lilly roils the obesity market

Baby aspirin cuts fat buildup in liver disease patients, in small study

hotspot

Positive childhood experiences can help future health

Colonoscopy prep: Liquid

Families look for replacement for GSK asthma drug Flovent

Positive childhood experiences can help future health

First over

Microsoft's Peter Lee: Generative AI could help doctors be more human

focus

focus

Wikipedia

focus